Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
IRVINE, CA / ACCESSWIRE / November 2, 2023 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024...
Year: 2023
Historic Collaborative Effort: Pharma Giants Rethink the Future of Life Sciences Transacting at MediLedger Face-to-Face Meeting, Hosted by Cencora
CONSHOHOCKEN, PA / ACCESSWIRE / November 2, 2023 / In what promises to be a pivotal moment for the pharmaceutical...
Juniper Advisory Adds Farley Reardon to its Health System M&A Advisory Group in Nashville
NASHVILLE, TN / ACCESSWIRE / November 2, 2023 / Juniper Advisory, a specialized investment banking firm focused exclusively on health...
Pressure BioSciences’ Patented BaroFold Technology Platform for High Efficiency Biopharmaceuticals Manufacturing Featured at International Bioprocess Conference by Leading Global Contract Biologics Manufacturer
Scientists at Lonza Biologics and Pressure BioSciences Presented PBIO's Patented BaroFold Platform for Breakthrough Efficiency and Economics Versus Current Manufacturing...
First Stop Health Announces Acquisition of SentryHealth
The virtual care providers' solutions will bring greater value to employer-clients and members with their steadfast dedication to delivering value-based...
Protagonist Therapeutics Announces Abstracts Selected for Oral and Poster Presentations at the American Society of Hematology 2023 Annual Meeting
Two oral presentations and three poster presentations elucidate new data relevant to rusfertide, a hepcidin mimetic with potential therapeutic value...
PolarSeal Sets Sight on Manufacturing Arm in the USA
PolarSeal®, a prominent provider of medical device contract manufacturing and adaptable material conversion, is excited to announce its strategic manufacturing...
Circle Care Services Launches ABA Therapy for Children With Autism in Georgia
Circle Care Services expands into its third state to offer innovative behavioral therapy to children diagnosed with autism spectrum disorder.MARIETTA,...
Renalogic Receives Second Consecutive Savings Certification From the Validation Institute for Dialysis Claims Repricing
Self-funded plans save 84.5% compared with their ‘Allowed Amount' when using Renalogic's ImpactProtect service.CHICAGO, IL / ACCESSWIRE / November 2,...
The Third Annual Sickle Cell Caregiver Summit: Empowering Caregivers on a Global Scale
The Sickle Cell Consortium Presents the 3rd Annual Sickle Cell Caregivers Summit Nov. 16-19, 2023NEW YORK, NY / ACCESSWIRE /...
Champions Oncology’s European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
HACKENSACK, NJ / ACCESSWIRE / November 2, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services...
Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License and Commercialization Agreement with Quadri Pharmaceuticals Store for Rare Intestinal Failure Diseases in Middle East Markets
Quadri Pharma will cover 50% of the costs of development activity up to a capped dollar contributionJaguar to host virtual...
Latina-Led Startup Announces Strong Study Results for AI-Assisted Technology for COPD
Using Acoustic Resonance, Samay's Passive Remote Monitoring Platform and Wearable Device Successfully Measures Air Trapping, a Biomarker to Detect ExacerbationsMOUNTAIN...
Bausch Health Announces Third-Quarter 2023 Results
Revenue of $2.24 billion, up 9% on both a Reported and Organic1 basisYear-over-year revenue growth in all segments on both...
Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET
ANN ARBOR, MI / ACCESSWIRE / November 2, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
Third quarter 2023 revenues of $1.8 billion; Company expects 2023 revenues of at least $6 billionSpikevax U.S. market share to...
Tryp Therapeutics Inc. Announces Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3.0 Million
KELOWNA, BC / ACCESSWIRE / November 2, 2023 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP), a clinical-stage biotechnology...
AlzeCure Presents at Redeye Life Science Day on November 23
STOCKHOLM, SE / ACCESSWIRE / November 02, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release...
Protagonist Announces Achievement of $50M Milestone Event After Third Patient is Dosed in Phase 3 Study of JNJ-2113 in Moderate-to-Severe Psoriasis
NEWARK, CA / ACCESSWIRE / November 1, 2023 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced the achievement...